Purchase Order 75F40125P00293
- Not listed
- This is a 3-year, labor-hour (LH) type contract for communication, administrative, and information disclosure support services for the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of. It is a direct 8(a) sole source award to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract has a ceiling value of $1,958,748.51 and a performance period through August 26, 2027. Aneon...
- This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...
- This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
- This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...
- The Food and Drug Administration awarded a direct 8(a) contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business based in Reston, Virginia, for supply chain technical support services to the Center for Drug Evaluation and Research. This labor-hour contract has a base period of 9.5 months with two 12-month option periods, carrying a total ceiling value of $4.2 million and an ultimate completion date of June 15, 2028. Work will be performed in Beltsville, Maryland. As an...
- The Food and Drug Administration (FDA) awarded an 8(a) direct contract to Aneon Brillient, LLC on August 2, 2024, for professional services supporting the Center for Drug Evaluation and Research (CDER). The definitive labor-hour contract has a 12-month base period with a 9-month option and a total ceiling value of approximately $4.3 million. Work will be performed in Calverton, Maryland, with an ultimate completion date of May 31, 2026. This award was not set aside for small businesses but...
- The U.S. Food and Drug Administration (FDA) has awarded a single-award, labor-hour (LH) contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture small disadvantaged business, to provide Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). This $1,479,584.76 ceiling value contract is a direct 8(a) sole source award with a period of performance through August 27, 2025. Aneon Brillient, a minority-owned limited...
- The Food and Drug Administration (FDA) awarded a definitive labor-hour contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture small business based in Reston, Virginia, to provide transcription services and support materials for the planning and management of Center for Drug Evaluation and Research (CDER) advisory committee meetings. The contract, valued at $642,543.27 with an ultimate completion date of February 27, 2026, was awarded as an 8(a) sole source set-aside on February...
- This is a direct 8(a) sole source award of a 3-year, labor-hour (LH) type contract for program support services to the U.S. Food and Drug Administration (FDA), Office of Policy, Legislation and International Affairs (OPLIA). The contract has a ceiling value of $1,619,126.45 and was awarded to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. Aneon Brillient specializes in providing professional services to the FDA, with experience...
- <p>The Food and Drug Administration (FDA) awarded a 1-year, firm fixed price type contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture, to provide program support staff for the FDA's Office of Global Policy and Strategy. This is a direct 8(a) sole source award with a ceiling value of $152,077.08. The contract will be performed in Calverton, Maryland and has a completion date of June 12, 2025.</p>
This is a $164,940.82 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for database administration support for the FDA's Center for Drug Evaluation and Research (CDER). The contract is a labor-hour type with a completion date of September 25, 2026. Aneon Brillient, an SBA certified 8(a) joint venture, has extensive experience providing professional services to the FDA, including medical and scientific writing, IT services, and specialized support like FOIA and webmaster services. This award builds on Aneon Brillient's existing FDA contract portfolio and its recently secured $999,999,999,999.00 OASIS+ Indefinite Delivery Contract, which allows the company to expand its federal contracting capabilities beyond the FDA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $164.9k | 9/25/25 |